These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 32484623)

  • 21. Proteoglycan Combined with Hyaluronic Acid and Hydrolyzed Collagen Restores the Skin Barrier in Mild Atopic Dermatitis and Dry, Eczema-Prone Skin: A Pilot Study.
    Lee YI; Lee SG; Kim J; Choi S; Jung I; Lee JH
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of atopic dermatitis with KAM-3008, a barrier-based, non-steroidal topical cream.
    Bomstein Y; Rozenblat S
    J Dermatolog Treat; 2015 Oct; 26(5):426-30. PubMed ID: 25893370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steroid-free emollient formulations reduce symptoms of eczema and improve quality of life.
    Weber TM; Babcock MJ; Herndon JH; Schoelermann AM; Filbry AW; Scherdin U; Neufang G; Rippke F
    J Drugs Dermatol; 2014 May; 13(5):589-95. PubMed ID: 24809884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with Synthetic Pseudoceramide Improves Atopic Skin, Switching the Ceramide Profile to a Healthy Skin Phenotype.
    Ishida K; Takahashi A; Bito K; Draelos Z; Imokawa G
    J Invest Dermatol; 2020 Sep; 140(9):1762-1770.e8. PubMed ID: 32014509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost and effectiveness of prescribing emollient therapy for atopic eczema in UK primary care in children and adults: a large retrospective analysis of the Clinical Practice Research Datalink.
    Moncrieff G; Lied-Lied A; Nelson G; Holy CE; Weinstein R; Wei D; Rowe S
    BMC Dermatol; 2018 Oct; 18(1):9. PubMed ID: 30373584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 24-hr, 28-day, and 7-day post-moisturizing efficacy of ceramides 1, 3, 6-II containing moisturizing cream compared with hydrophilic cream on skin dryness and barrier disruption in senile xerosis treatment.
    Lueangarun S; Tragulplaingam P; Sugkraroek S; Tempark T
    Dermatol Ther; 2019 Nov; 32(6):e13090. PubMed ID: 31585489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colloidal oatmeal formulations as adjunct treatments in atopic dermatitis.
    Fowler JF; Nebus J; Wallo W; Eichenfield LF
    J Drugs Dermatol; 2012 Jul; 11(7):804-7. PubMed ID: 22777219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients.
    Hon KL; Pong NH; Wang SS; Lee VW; Luk NM; Leung TF
    Drugs R D; 2013 Mar; 13(1):37-42. PubMed ID: 23456759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Halobetasol Propionate Lotion, 0.05% Provides Superior Hydration Compared to Halobetasol Propionate Cream, 0.05% in a Double-Blinded Study of Occlusivity and Hydration.
    Grove G; Zerweck C; Houser T; Andrasfay A; Gauthier B; Holland C; Piacquadio D
    J Drugs Dermatol; 2017 Feb; 16(2):140-144. PubMed ID: 28300856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial.
    Wirén K; Nohlgård C; Nyberg F; Holm L; Svensson M; Johannesson A; Wallberg P; Berne B; Edlund F; Lodén M
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1267-72. PubMed ID: 19508310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ARTICLE: Colloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic Dermatitis.
    Allais B; Friedman A
    J Drugs Dermatol; 2020 Oct; 19(10):s4-s7. PubMed ID: 33026768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isosorbide Di-(Linoleate/Oleate) Stimulates Prodifferentiation Gene Expression to Restore the Epidermal Barrier and Improve Skin Hydration.
    Bojanowski K; Swindell WR; Cantor S; Chaudhuri RK
    J Invest Dermatol; 2021 Jun; 141(6):1416-1427.e12. PubMed ID: 33181142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of eczema calming lotion on the stratum corneum in atopic dermatitis: Corneodesmosin and intercellular lipid lamellae.
    Ilarslan H; Lathrop WF; Dobkowski B; Hawkins SS; Scott J; Bajor J; Mayes AE
    Int J Cosmet Sci; 2024 Aug; 46(4):516-525. PubMed ID: 39113306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical Moisturizer Meaningfully Reduces Disease Severity in Atopic Patients With Xerosis.
    Kelly KA; Cook MK; Singh R; Perche PO; Balogh EA; Richardson IM; Feldman SR
    J Drugs Dermatol; 2023 Dec; 22(12):e51-e52. PubMed ID: 38051832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prebiotic Colloidal Oat Supports the Growth of Cutaneous Commensal Bacteria Including
    Liu-Walsh F; Tierney NK; Hauschild J; Rush AK; Masucci J; Leo GC; Capone KA
    Clin Cosmet Investig Dermatol; 2021; 14():73-82. PubMed ID: 33500646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of pimecrolimus compared with triamcinolone acetonide cream on skin barrier structure in atopic dermatitis: a randomized, double-blind, right-left arm trial.
    Jensen JM; Weppner M; Dähnhardt-Pfeiffer S; Neumann C; Bräutigam M; Schwarz T; Fölster-Holst R; Proksch E
    Acta Derm Venereol; 2013 Sep; 93(5):515-9. PubMed ID: 23571785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm).
    Lodén M; Andersson AC; Lindberg M
    Br J Dermatol; 1999 Feb; 140(2):264-7. PubMed ID: 10233220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of interleukin-13 signalling improves skin barrier function and biology in patients with moderate-to-severe atopic dermatitis.
    Sander N; Stölzl D; Fonfara M; Hartmann J; Harder I; Suhrkamp I; Jakaša I; van den Bogaard E; van Vlijmen-Willems I; Szymczak S; Rodriguez E; Gerdes S; Weidinger S
    Br J Dermatol; 2024 Aug; 191(3):344-350. PubMed ID: 38531691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Objective evaluation of the efficacy of daily topical applications of cosmetics bases using the hairless mouse model of atopic dermatitis.
    Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Sakai Y; Tagami H
    Skin Res Technol; 2005 Aug; 11(3):209-17. PubMed ID: 15998334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial).
    Totté J; de Wit J; Pardo L; Schuren F; van Doorn M; Pasmans S
    Trials; 2017 Aug; 18(1):404. PubMed ID: 28859690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.